EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-occlusive Disease | MicrobiomeTrials← Back to trialsNCT07864649
EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-occlusive Disease
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2027-05-01Est. Completion: 2031-11-30
Enrollment target: 170 participants Other microbiome trials you might be interested in
Non-valvular Atrial FibrillationStrokeSystemic Embolism
The purpose of this study is to compare the safety and effectiveness of Laminar Left Atrial Appendage Closure (LAAC) dev…
Birmingham, United StatesCompleted Dec 1, 2028
StrokeIschemicAtrial FibrillationIntracrnaial ArterioscelrosisArteriosclerosis
This trial aims to compare the safety and efficacy of apixaban alone versus apixaban combined with clopidogrel in patien…
Seoul, South Korea
Est. completion Jul 2029